150 related articles for article (PubMed ID: 22202345)
1. [mFOLFOX6 and FOLFIRI/bevacizumab treatment in a patient on hemodialysis with metastatic colon cancer].
Kuwabara H; Baba H; Wakabayashi M; Nakamura H; Sanada T; Baba H; Nakajima K; Goseki N
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2250-2. PubMed ID: 22202345
[TBL] [Abstract][Full Text] [Related]
2. [A case of advanced colon cancer with peritoneal dissemination effectively treated with modified FOLFOX6 chemotherapy].
Tanaka K; Hirai K; Ogawa H; Toya H; Totsuka O; Yoshinari D; Sunose Y; Takeyoshi I
Gan To Kagaku Ryoho; 2012 Jun; 39(6):993-5. PubMed ID: 22705700
[TBL] [Abstract][Full Text] [Related]
3. Clinical and radiological response with FOLFOXIRI and bevacizumab as third-line therapy after mFOLFOX6 and FOLFIRI failure.
de Melo JV; Vieira de Melo MS; Abad MH
Anticancer Drugs; 2011 Jun; 22 Suppl 2():S19-20. PubMed ID: 21768793
[TBL] [Abstract][Full Text] [Related]
4. [FOLFIRI with bevacizumab chemotherapy for a patient with recurrence of rectal cancer under haemodialysis for chronic renal failure].
Hoshino H; Ishii Y; Hasegawa H; Endo T; Ochiai H; Hoshino Y; Matsunaga A; Shigeta K; Seo Y; Hoshino G; Kitagawa Y
Gan To Kagaku Ryoho; 2012 Jun; 39(6):983-6. PubMed ID: 22705698
[TBL] [Abstract][Full Text] [Related]
5. [Ovarian metastasis after complete response of colon cancer].
Nishimura T; Maeda Y; Okada T; Nakamura M; Sakata K; Setoguchi M; Kawasaki N
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2263-5. PubMed ID: 20037390
[TBL] [Abstract][Full Text] [Related]
6. [Bevacizumab in combination with mFOLFOX6 or FOLFIRI for previously treated metastatic colorectal cancer].
Koyama M; Murata A; Kimura Y; Sakamoto Y; Morohashi H; Kimura N; Gasa F; Sato J; Terui K; Awatsu A; Hakamada K
Gan To Kagaku Ryoho; 2010 Jun; 37(6):1069-73. PubMed ID: 20567110
[TBL] [Abstract][Full Text] [Related]
7. [A case of sigmoid colon cancer with peritoneal dissemination responding to third-line therapy employing bevacizumab combination therapy after failure of FOLFOX and FOLFIRI].
Tamura T; Ishikawa N; Koui S; Nakashima H; Minagawa N; Hachiya Y; Hirata K; Sako T; Fukuyama T; Hirano Y
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1813-6. PubMed ID: 20841954
[TBL] [Abstract][Full Text] [Related]
8. [A case of metastatic rectal cancer in an extremely aged patient successfully treated with mFOLFOX6 plus bevacizumab].
Yokoyama M; Urakawa M; Murakami T; Amano K; Ohsawa T; Okada N; Kumamoto K; Ishibashi K; Ishida H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2241-3. PubMed ID: 22202342
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of chemotherapy plus bevacizumab as second-line therapy for patients with metastatic colorectal cancer that progressed on bevacizumab with chemotherapy: the Gunma Clinical Oncology Group (GCOG) trial 001 SILK study.
Tsutsumi S; Ishibashi K; Uchida N; Ojima H; Hosouchi Y; Yashuda N; Kigure W; Yamauchi S; Asao T; Ishida H; Kuwano H
Oncology; 2012; 83(3):151-7. PubMed ID: 22889925
[TBL] [Abstract][Full Text] [Related]
10. [Third-line therapy in a patient with recurrent colon cancer undergoing hemodialysis].
Matsuda M; Seyama Y; Inada K; Miyata Y; Shida D; Maeshiro T; Miyamoto S; Umekita N
Gan To Kagaku Ryoho; 2013 Oct; 40(10):1397-400. PubMed ID: 24196079
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of bevacizumab for advanced colorectal cancer].
Naito M; Hoshino S; Noda N; Nakano M; Matsuo K; Yamauchi Y; Shinohara T; Tanaka S; Yamashita Y
Gan To Kagaku Ryoho; 2010 Jan; 37(1):83-8. PubMed ID: 20087037
[TBL] [Abstract][Full Text] [Related]
12. [A Case of Ascending Colon Cancer Showing Marked Reduction of Ascites by Bevacizumab Combination Chemotherapy].
Kusama T; Higashida A; Komatsubara T; Nishigori H; Kokado Y; Ishii M
Gan To Kagaku Ryoho; 2015 Sep; 42(9):1119-21. PubMed ID: 26469173
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of bolus 5-fluorouracil for recurrent or metastatic colorectal cancer treated with FOLFOX+ BevacizumabTherapy].
Yoshida Y; Hasegawa J; Nishimura J; Hirota M; Kim Y; Nezu R
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1293-6. PubMed ID: 21829066
[TBL] [Abstract][Full Text] [Related]
14. The clinical efficacy of FOLFIRI and bevacizumab in combination as first-line therapy of metastatic colorectal cancer.
Grothey E; Chu E
Clin Colorectal Cancer; 2007 Sep; 6(9):621-4. PubMed ID: 17945033
[No Abstract] [Full Text] [Related]
15. [A case of drug-induced lung injury associated with chemotherapy (FOLFOX6, FOLFIRI, Bevacizumab) for an advanced colon cancer].
Komaki C; Hanatate F; Kobayashi K
Gan To Kagaku Ryoho; 2011 Jan; 38(1):113-6. PubMed ID: 21368470
[TBL] [Abstract][Full Text] [Related]
16. Partial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report).
Sawai K; Goi T; Koneri K; Katayama K; Yamaguchi A
World J Surg Oncol; 2013 Aug; 11(1):203. PubMed ID: 23957924
[TBL] [Abstract][Full Text] [Related]
17. [Long-term survival of a patient with advanced colon cancer and para-aortic lymph node metastases treated with re-administration of high-dose molecular targeted agent bevacizumab].
Ebisawa Y; Chisato N; Okayama T; Tani C; Kono T; Taniguchi M; Furukawa H
Gan To Kagaku Ryoho; 2013 Oct; 40(10):1401-4. PubMed ID: 24196080
[TBL] [Abstract][Full Text] [Related]
18. [Huge unresectable multiple hepatic metastases of rectum cancer responding to combined therapy with FOLFIRI +bevacizumab - a case report].
Tagami Y; Ogata S; Katakawa M; Bando Y
Gan To Kagaku Ryoho; 2012 Feb; 39(2):317-9. PubMed ID: 22333652
[TBL] [Abstract][Full Text] [Related]
19. Sequential or combination chemotherapy for a patient with mCRC?
Arnold D
Cancer Treat Rev; 2008; 34 Suppl 2():S12-6. PubMed ID: 19101403
[TBL] [Abstract][Full Text] [Related]
20. [A case of liver metastases from rectal cancer showed a complete response by FOLFIRI and bevacizumab chemotherapy].
Kuwada A; Nakamitsu A; Imamura Y; Kouyama M; Uekami S; Touge K; Taogoshi H; Fukuda Y; Daimaru H
Gan To Kagaku Ryoho; 2010 Dec; 37(13):2937-40. PubMed ID: 21160275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
